Petros Pharmaceuticals, Inc.
PTPI
$0.01
$0.001.41%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -336.50K | -922.70K | 5.43M | -2.26M | -9.27M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 73.40K | 74.10K | -8.90M | 764.00K | 10.08M |
| Change in Net Operating Assets | -670.50K | -285.30K | 456.30K | -164.10K | 162.20K |
| Cash from Operations | -933.50K | -1.13M | -3.01M | -1.66M | 965.40K |
| Capital Expenditure | -- | -- | -- | -- | 19.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -24.60K |
| Cash from Investing | -- | -- | -- | -- | -5.40K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 0.00 | -- | 8.71M | -- |
| Repurchase of Common Stock | -- | -- | -204.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 0.00 | -117.30K | -224.20K | -- | -1.14M |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | 0.00 | -117.30K | -428.20K | 8.71M | -1.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -933.50K | -1.25M | -3.44M | 7.05M | -184.70K |